|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lucio-Eterovic AK, Piao Y and de Groot JF:
Mediators of glioblastoma resistance and invasion during
antivascular endothelial growth factor therapy. Clin Cancer Res.
15:4589–4599. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poincloux R, Lizárraga F and Chavrier P:
Matrix invasion by tumour cells: A focus on MT1-MMP trafficking to
invadopodia. J Cell Sci. 122:3015–3024. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fillmore HL, VanMeter TE and Broaddus WC:
Membrane-type matrix metalloproteinases (MT-MMPs): Expression and
function during glioma invasion. J Neurooncol. 53:187–202. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Guo P, Imanishi Y, Cackowski FC, Jarzynka
MJ, Tao HQ, Nishikawa R, Hirose T, Hu B and Cheng SY: Up-regulation
of angiopoietin-2, matrix metalloprotease-2, membrane type 1
metalloprotease, and laminin 5 gamma 2 correlates with the
invasiveness of human glioma. Am J Pathol. 166:877–890. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang L, Yuan J, Tu Y, Mao X, He S, Fu G,
Zong J and Zhang Y: Co-expression of MMP-14 and MMP-19 predicts
poor survival in human glioma. Clin Transl Oncol. 15:139–145. 2013.
View Article : Google Scholar
|
|
8
|
Rath O and Kozielski F: Kinesins and
cancer. Nat Rev Cancer. 12:527–539. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang CQ, Qu X, Zhang XY, Zhou CJ, Liu GX,
Dong ZQ, Wei FC and Sun SZ: Overexpression of Kif2a promotes the
progression and metastasis of squamous cell carcinoma of the oral
tongue. Oral Oncol. 46:65–69. 2010. View Article : Google Scholar
|
|
10
|
Wang J, Ma S, Ma R, Qu X, Liu W, Lv C,
Zhao S and Gong Y: KIF2A silencing inhibits the proliferation and
migration of breast cancer cells and correlates with unfavorable
prognosis in in breast cancer. BMC Cancer. 14:4612014. View Article : Google Scholar
|
|
11
|
Liu Z, Rebowe RE, Wang Z, Li Y, Wang Z,
DePaolo JS, Guo J, Qian C and Liu W: KIF3a promotes proliferation
and invasion via Wnt signaling in advanced prostate cancer. Mol
Cancer Res. 12:491–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nangaku M, Sato-Yoshitake R, Okada Y, Noda
Y, Takemura R, Yamazaki H and Hirokawa N: KIF1B, a novel
microtubule plus end-directed monomeric motor protein for transport
of mitochondria. Cell. 79:1209–1220. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lyons DA, Naylor SG, Scholze A and Talbot
WS: Kif1b is essential for mRNA localization in oligodendrocytes
and development of myelinated axons. Nat Genet. 41:854–858. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao C, Takita J, Tanaka Y, Setou M,
Nakagawa T, Takeda S, Yang HW, Terada S, Nakata T, Takei Y, et al:
Charcot-Marie-Tooth disease type 2A caused by mutation in a
microtubule motor KIF1Bbeta. Cell. 105:587–597. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dong Z, Xu X, Du L, Yang Y, Cheng H, Zhang
X, Li Z, Wang L, Li J, Liu H, et al: Leptin-mediated regulation of
MT1-MMP localization is KIF1B dependent and enhances gastric cancer
cell invasion. Carcinogenesis. 34:974–983. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang YM, Feng AL, Zhou CJ, Liang XH, Mao
HT, Deng BP, Yan S, Sun JT, Du LT, Liu J, et al: Aberrant
expression of chemokine receptor CCR4 in human gastric cancer
contributes to tumor-induced immunosuppression. Cancer Sci.
102:1264–1271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao P, Li XG, Yang M, Shao Q, Wang D, Liu
S, Song H, Song B, Zhang Y and Qu X: Hypoxia suppresses the
production of MMP-9 by human monocyte-derived dendritic cells and
requires activation of adenosine receptor A2b via cAMP/PKA
signaling pathway. Mol Immunol. 45:2187–2195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang W, Sima N, Kong D, Luo A, Gao Q, Liao
S, Li W, Han L, Wang J, Wang S, et al: Selective targeting of
HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic
adenovirus and its enhanced effect with radiotherapy in vitro and
vivo. Cancer Lett. 291:67–75. 2010. View Article : Google Scholar
|
|
20
|
Liu Q, Li G, Li R, Shen J, He Q, Deng L,
Zhang C and Zhang J: IL-6 promotion of glioblastoma cell invasion
and angiogenesis in U251 and T98G cell lines. J Neurooncol.
100:165–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Palfi S, Swanson KR, De Boüard S, Chrétien
F, Oliveira R, Gherardi RK, Kros JM, Peschanski M and Christov C:
Correlation of in vitro infiltration with glioma histological type
in organotypic brain slices. Br J Cancer. 91:745–752.
2004.PubMed/NCBI
|
|
22
|
Bie L, Zhao G, Wang YP and Zhang B:
Kinesin family member 2C (KIF2C/MCAK) is a novel marker for
prognosis in human gliomas. Clin Neurol Neurosurg. 114:356–360.
2012. View Article : Google Scholar
|
|
23
|
Wang Q, Wang L, Li D, Deng J, Zhao Z, He
S, Zhang Y and Tu Y: Kinesin family member 14 is a candidate
prognostic marker for outcome of glioma patients. Cancer Epidemiol.
37:79–84. 2013. View Article : Google Scholar
|
|
24
|
Takahashi S, Fusaki N, Ohta S, Iwahori Y,
Iizuka Y, Inagawa K, Kawakami Y, Yoshida K and Toda M:
Downregulation of KIF23 suppresses glioma proliferation. J
Neurooncol. 106:519–529. 2012. View Article : Google Scholar
|
|
25
|
Ulasov I, Yi R, Guo D, Sarvaiya P and
Cobbs C: The emerging role of MMP14 in brain tumorigenesis and
future therapeutics. Biochim Biophys Acta. 1846:113–120.
2014.PubMed/NCBI
|
|
26
|
Annabi B, Laflamme C, Sina A, Lachambre MP
and Béliveau R: A MT1-MMP/NF-kappaB signaling axis as a checkpoint
controller of COX-2 expression in CD133+ U87
glioblastoma cells. J Neuroinflammation. 6:82009. View Article : Google Scholar
|
|
27
|
Hardee ME and Zagzag D: Mechanisms of
glioma-associated neovascularization. Am J Pathol. 181:1126–1141.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deryugina EI, Soroceanu L and Strongin AY:
Up-regulation of vascular endothelial growth factor by
membrane-type 1 matrix metalloproteinase stimulates human glioma
xenograft growth and angiogenesis. Cancer Res. 62:580–588.
2002.PubMed/NCBI
|
|
29
|
Akita H, Kogure K, Moriguchi R, Nakamura
Y, Higashi T, Nakamura T, Serada S, Fujimoto M, Naka T, Futaki S,
et al: Nanoparticles for ex vivo siRNA delivery to dendritic cells
for cancer vaccines: programmed endosomal escape and dissociation.
J Control Release. 143:311–317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yagi N, Manabe I, Tottori T, Ishihara A,
Ogata F, Kim JH, Nishimura S, Fujiu K, Oishi Y, Itaka K, et al: A
nanoparticle system specifically designed to deliver short
interfering RNA inhibits tumor growth in vivo. Cancer Res.
69:6531–6538. 2009. View Article : Google Scholar : PubMed/NCBI
|
